Reduced Episignature Classifier for Sotos Syndrome as a Supporting Diagnostic and Research Tool

Sotos syndrome, an autosomal dominant neurodevelopmental disorder caused by pathogenic variants in the NSD1 gene, exhibits a distinct genome-wide DNA methylation episignature characterized by widespread hypomethylation. While genome-wide methylation signatures provide robust diagnostic accuracy, their implementation in routine clinical practice is limited by cost and technical complexity. This study aimed to reduce the Sotos syndrome episignature to a confined set of CpG sites intended for Sanger bisulfite sequencing. We selected four loci containing CpG dinucleotides with the most significant methylation changes based on published data. Bisulfite Sanger sequencing was performed on patients with the molecularly confirmed Sotos syndrome and healthy controls. The obtained methylation levels of the analyzed loci were then used as features to build a binary classification model using machine learning methods. We employed the Random Forest-based method to conduct a feature selection, which identified two CpG sites (chr6:28601375 and chr6:28601440) as the most important predictors. A logistic regression classification model was developed using selected CpG sites. The resulting two-predictor model demonstrated excellent performance and achieved 100% accuracy on the held-out test set. All Sotos syndrome samples were classified correctly, while Malan syndrome samples showed methylation levels comparable to controls. Two samples with VUS in the NSD1 gene were classified together with all samples with pathogenic NSD1 variants. For these two cases, we performed a de novo assessment of the variant status and reclassified the variants (NSD1(NM_022455.5): c.6523T>C and c.8005del, respectively) into likely pathogenic, confirming the validity of the results of the reduced episignature analysis. Thus, our cost-effective approach can potentially serve as a supporting diagnostic and research tool, particularly for variant reclassification and differential diagnosis in resource-limited settings.

Authors

Institutions

Publication Details

Journal
Current Issues in Molecular Biology
Published
2026-11-20
DOI
https://doi.org/10.3390/cimb48111254
Primary Topic
Genetic Syndromes and Imprinting
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Reduced Episignature Classifier for Sotos Syndrome as a Supporting Diagnostic and Research Tool

Alexey I. Kalinkin, Anna V. Efremova, Dmitry V. Zaletaev, Alexander S. Tanas et al.
2 links
Current Issues in Molecular Biology
Genetic Syndromes and Imprinting
article

Reduced Episignature Classifier for Sotos Syndrome as a Supporting Diagnostic and Research Tool

Alexey I. Kalinkin, Anna V. Efremova, Dmitry V. Zaletaev, Alexander S. Tanas, Anton S. Smirnov, V. V. Strelnikov, Ilya V. Volodin, О. А. Земляная, Natalia A. Semenova, Sergey I Kutsev, Marina V. Nemtsova
article en

Abstract

Sotos syndrome, an autosomal dominant neurodevelopmental disorder caused by pathogenic variants in the NSD1 gene, exhibits a distinct genome-wide DNA methylation episignature characterized by widespread hypomethylation. While genome-wide methylation signatures provide robust diagnostic accuracy, their implementation in routine clinical practice is limited by cost and technical complexity. This study aimed to reduce the Sotos syndrome episignature to a confined set of CpG sites intended for Sanger bisulfite sequencing. We selected four loci containing CpG dinucleotides with the most significant methylation changes based on published data. Bisulfite Sanger sequencing was performed on patients with the molecularly confirmed Sotos syndrome and healthy controls. The obtained methylation levels of the analyzed loci were then used as features to build a binary classification model using machine learning methods. We employed the Random Forest-based method to conduct a feature selection, which identified two CpG sites (chr6:28601375 and chr6:28601440) as the most important predictors. A logistic regression classification model was developed using selected CpG sites. The resulting two-predictor model demonstrated excellent performance and achieved 100% accuracy on the held-out test set. All Sotos syndrome samples were classified correctly, while Malan syndrome samples showed methylation levels comparable to controls. Two samples with VUS in the NSD1 gene were classified together with all samples with pathogenic NSD1 variants. For these two cases, we performed a de novo assessment of the variant status and reclassified the variants (NSD1(NM_022455.5): c.6523T>C and c.8005del, respectively) into likely pathogenic, confirming the validity of the results of the reduced episignature analysis. Thus, our cost-effective approach can potentially serve as a supporting diagnostic and research tool, particularly for variant reclassification and differential diagnosis in resource-limited settings.

Current Issues in Molecular BiologyVol. 48(11)
Sechenov University (RU), Pirogov Russian National Research Medical University (RU), Research Centre for Medical Genetics (RU)
Ministry of Science and Higher Education of the Russian Federation
Good health and well-being
Genetic Syndromes and Imprinting
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon